SRDX News and Press, Surmodics Inc. From 09/23/21

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Surmodics, Inc. (SRDX) Q3 2021 Results Conference Call August 4, 2021 8:30 AM ET Company Participants Tim Arens - Senior Vice President of Finance and Chief Financial Officer Gary Maharaj - President and Chief Executive Officer Conference Call Participants Mike Matson - Needham & Company ...

Image source: The Motley Fool. Surmodics Inc (NASDAQ: SRDX) Q3 2021 Earnings Call Aug 4, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Surmodics Inc (SRDX) Q3 2021 Earnings Call Transcript

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2021 third quarter ended June 30, 2021 and updated its financial outlook for its fiscal 2021. Summary of Thi...

Standalone arterial mechanical thrombectomy device removes 30 cm of subacute thrombus in first clinical case Surmodics, Inc. (NASDAQ: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that J. Michael...

Webcast is Live at 7:30 a.m. (CT) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its third quarter fiscal 2021 conference call on Wednes...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...